泌乳素瘤女性妊娠期间及产后糖尿病风险评估
研究纳入52例接受卡麦角林治疗的泌乳素瘤患者,在孕前、妊娠期及产后长达10年评估糖代谢。妊娠期泌乳素逐渐升高而空腹血糖保持稳定,孕前泌乳素水平可预测妊娠晚期空腹血糖;母乳喂养至6个月与产后4年和10年空腹血糖较低相关。作者建议进行孕前代谢管理以降低妊娠期及2型糖尿病风险。
要点
- 妊娠期泌乳素逐渐升高,空腹血糖保持稳定,两者在第一和第三孕期呈负相关。
- 孕前血清泌乳素水平是妊娠晚期空腹血糖的预测生物标志物(t=2.603;P=.048)。
- 母乳喂养至6个月与产后4年和10年空腹血糖较低相关。
核心结论
- 孕前低泌乳素水平可能对妊娠期空腹血糖不利。
- 卡麦角林使用时长和剂量可能影响长期糖耐量,家族史和BMI亦相关。
- 作者建议进行孕前代谢管理以降低妊娠期和2型糖尿病风险。
研究设计与样本
- 共纳入52例接受卡麦角林治疗的患者,在孕前、妊娠期及产后长达10年进行评估。
- 妊娠期停用卡麦角林,产后57.7%的患者因复发性高泌乳素血症重新开始用药。
- 评估激素(血清泌乳素)和代谢(糖化血红蛋白A1c、空腹血糖、糖耐量)参数。
主要发现
- 妊娠期泌乳素逐渐升高,空腹血糖保持稳定;第一孕期(P=.032)和第三孕期(P=.048)泌乳素与空腹血糖呈负相关。
- 妊娠期泌乳素百分比升高与第三孕期空腹血糖呈负相关;孕前血清泌乳素是第三孕期空腹血糖的预测生物标志物(t=2.603;P=.048)。
- 年龄较大、第一孕期糖化血红蛋白A1c较低且产后3年空腹血糖较低的患者所分娩婴儿出生体重较低。
- 母乳喂养至6个月与产后4年和10年空腹血糖较低相关;产后10年BMI与空腹血糖呈正相关(P=.03),尤其在需要更高卡麦角林剂量的超重/肥胖患者中。
- 因复发性高泌乳素血症需重新使用卡麦角林的患者母乳喂养持续时间较短,且产后2年空腹血糖较高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Prolactin (PRL) is a crucial mediator of glucoinsulinemic metabolism. OBJECTIVE: This work aims to dissect glucose metabolism during and after pregnancy in patients with prolactinomas. METHODS: A total of 52 patients treated with cabergoline (CAB) were evaluated before conception, during pregnancy, and up to 10 years after delivery. During pregnancy, CAB was discontinued, while it was restarted in 57.7% of patients after delivery, due to recurrent hyperprolactinemia (RH). Hormonal (serum PRL) and metabolic (glycated hemoglobin A1c [HbA1c], fasting glucose [FG], glucose tolerance) parameters were assessed. RESULTS: During pregnancy, PRL gradually increased, while FG remained stable. An inverse correlation between PRL and FG was found in the first (P = .032) and third (P = .048) trimester. PRL percentage increase across pregnancy was inversely correlated with third-trimester FG. Serum PRL before conception emerged as a predictive biomarker of third-trimester FG (t = 2.603; P = .048). Older patients with lower HbA1c in the first trimester and lower FG at 3 years post partum delivered infants with reduced birth weight. Breastfeeding up to 6 months correlated with lower FG at 4 and 10 years post partum. A positive correlation between BMI and FG at 10 years after delivery (P = .03) was observed, particularly in overweight/obese patients requiring higher CAB doses. Patients with RH who had to restart CAB showed shorter breastfeeding duration and higher FG at 2 years post partum. CONCLUSION: Low PRL levels before pregnancy may be detrimental to FG during pregnancy. CAB duration and dose may influence long-term glucose tolerance, besides family history and BMI. Preconception metabolic management should be recommended to reduce the risk of gestational and type 2 diabetes mellitus.
引用
- Scairati R, Auriemma RS, Di Meglio S, et al. Risk Assessment of Diabetes Mellitus During and After Pregnancy in Women With Prolactinomas. J Clin Endocrinol Metab. 2024. PMID: 38693775. doi:10.1210/clinem/dgae289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。